Efficient Transfer of Public Scientific R&D to Private Firms

  • T. V. S. Ramamohan Rao
Part of the International Studies in Entrepreneurship book series (ISEN, volume 19)

2.1 Introduction

The development and commercialization of modern technologies, especially biotechnology, has been knowledge intensive. No private firm has adequate scientific manpower or the laboratory tools to undertake fundamental activities in the early phases of development. Perforce they must be developed and incubated in specialized research institutions and transferred to private firms through appropriate organizational mechanisms. The dependence on such agents is also due to high costs of R&D and significant risks (both technological as well as appropriability) associated with such technological developments. These technologies are also such that a formal transfer of blueprints (or the disclosure at the patent filing stage) is generally inadequate to make efficient use of the results of R&D. The transfer of informal knowledge,1 made possible only through close interaction with scientists, has become a compulsion.

One of the fundamental debates is about the role of the public...


Venture Capital Public Institution Private Firm Institutional Mechanism Informal Knowledge 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Alfranca, O. and Huffman, W. (2003). Aggregate private R&D investments in agriculture: The role of incentives, public policies, and institutions. Economic Development and Cultural Change, 52(1):1–21.CrossRefGoogle Scholar
  2. Arora, A. (1996). Contracting for tacit knowledge: the provision of technical services in technology licensing contracts. Journal of Development Economics, 50(2):233–256.CrossRefGoogle Scholar
  3. Berglund, D. and Clarke, M. (2000). Using Research and Development to Grow State Economies. National Governors Association.Google Scholar
  4. Byerlee, D. and Fischer, K. (2001). Accessing modern science: Policy and institutional options for agricultural biotechnology in developing countries. IP Strategy Today, 1:1–27.Google Scholar
  5. Chaturvedi, S. (2002). Agricultural biotechnology and new trends in IPR regime. Economic and Political Weekly, 37(13):1212–1222.Google Scholar
  6. Filson, D. and Morales, R. (2005). Equity links and information acquisition in biotechnology alliances. Journal of Economic Behavior and Organization, 59:1–28.CrossRefGoogle Scholar
  7. Fischer, K. and Byerlee, D. (2001). Managing Intellectual Property and Commercialization in Public Research Organizations. World Bank, Rural Development Dept.Google Scholar
  8. Gerpacio, R. (2003). The roles of public sector versus private sector in R&D and technology generation: The case of maize in Asia. Agricultural Economics, 29(3):319–330.CrossRefGoogle Scholar
  9. Giesecke, S. (2000). The contrasting roles of government in the development of biotechnology industry in the US and Germany. Research Policy, 29:205–223.CrossRefGoogle Scholar
  10. Horsch, R. and Montgomery, J. (2004). Why we partner: Collaborations between the private and public sectors for food security and poverty alleviation through agricultural biotechnology. AgBioForum, 7(1&2):80–83.Google Scholar
  11. Ishibashi, I. and Matsumura, T. (2005). R&D competition between public and private sectors. European Economic Review.Google Scholar
  12. Just, R. and Hueth, D. (1993). Multimarket exploitation: The case of biotechnology and chemicals. American Journal of Agricultural Economics, 75(4):936–945.CrossRefGoogle Scholar
  13. Kalaitzandonakes, N. (1999). The agricultural knowledge system: Appropriate roles and interactions for the public and private sectors. AgBioForum, 2(1):1–3.Google Scholar
  14. Kawasaki, S. and McMillan, J. (1987). The design of contracts: Evidence from Japanese subcontracting. Journal of the Japanese and International Economics, 1:327–349.CrossRefGoogle Scholar
  15. Lehrer, M. and Asakawa, K. (2004). Rethinking the public sector: Idiosyncracies of biotechnology commercialization as motors for national R&D Reform in Germany and Japan. Research Policy, 33:921–938.CrossRefGoogle Scholar
  16. Maria, A., Ruet, J., and Zerah, M. (2002). Biotechnology in India. Report prepared for the French Embassy in New Delhi.Google Scholar
  17. Rai, A. (2005a). International public goods and transfer of technology under a globalized intellectual property regime. Chapter Property Rights and Collective Action: The Case of Biotechnology Research with Low Commercial Value. Cambridge: Cambridge University Press.Google Scholar
  18. Rai, A. (2005b). Open and collaborative research: A new model for biomedicine. In R. Hahn, editor, Intellectual property Rights in Frontier Industries: Software and Biotech. Washington: Brookings Press.Google Scholar
  19. Rai, A. and Eisenberg, R. (2004). The public and private in biopharmaceutical research. Technical report.Google Scholar
  20. Raina, R. (2003). Biotechnology in the national agricultural research system: A case for institutional reform. Asian Biotechnology and Development Review, 5:27–56.Google Scholar
  21. Ramani, S. (2002). Who is interested in biotech? R&D strategies, knowledge base, and market sales of Indian biopharmaceutical firms. Research Policy, 31:381–398.CrossRefGoogle Scholar
  22. Rao, T. V. S. R. (2004). Sharing fixed costs in franchise contracts. Indian Economic Journal, 51:23– 34.Google Scholar
  23. Rao, T. V. S. R. (2005). Organizational learning, complementary assets, and network organizations. In Presented at the International Conference on Productivity and Quality Research, IIT, New Delhi.Google Scholar
  24. Rao, T. V. S. R. (2006). Dynamics of the Transfer of Public Scientific R&D to Private Firms.Google Scholar
  25. Sharma, M. (2000). India: Biotechnology Research and Development. Available at
  26. Sharma, R. and Rao, T. (2005). Information Asymmetry in International Joint Ventures.Google Scholar
  27. Sharma, R. and Rao, T. (2006). Technology Transfer in International Joint Ventures.Google Scholar
  28. Sonka, S. and Pueppke, S. (1999). Exploring the publics role in agricultural biotechnology research. AgBioForum, 2:33–36.Google Scholar
  29. Visalakshi, S. and Sandhya, G. (1997). An analysis of biotechnology and non-biotechnology R&D Capabilities in the Indian Pharmaceutical Industry. R&D Management, 27:165–175.CrossRefGoogle Scholar
  30. Wolf, S. and Zilberman, D. (1999). Public science, biotechnology, and the industrial organization of agrifood systems. AgBioForum, 2:37–42.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • T. V. S. Ramamohan Rao
    • 1
  1. 1.Indian Institute of TechnologyKanpurIndia

Personalised recommendations